Release Date: 07/07/14 14:39 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 204.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%